Cargando…
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
BACKGROUND & AIMS: Metabolic reprogramming is recognized as a cancer hallmark intimately linked to tumor hypoxia, which supports rapid tumor growth and mitigates the consequential oxidative stress. Phosphofructokinase-fructose bisphosphatase (PFKFB) is a family of bidirectional glycolytic enzyme...
Autores principales: | Kam, Charles Shing, Ho, Daniel Wai-Hung, Ming, Vanessa Sheung-In, Tian, Lu, Sze, Karen Man-Fong, Zhang, Vanilla Xin, Tsui, Yu-Man, Husain, Abdullah, Lee, Joyce Man-Fong, Wong, Carmen Chak-Lui, Chan, Albert Chi-Yan, Cheung, Tan-To, Chan, Lo-Kong, Ng, Irene Oi-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140800/ https://www.ncbi.nlm.nih.gov/pubmed/36806581 http://dx.doi.org/10.1016/j.jcmgh.2023.02.004 |
Ejemplares similares
-
Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
por: Tian, Lu, et al.
Publicado: (2021) -
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1
por: Zhang, Vanilla Xin, et al.
Publicado: (2021) -
RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma
por: Ma, Wei, et al.
Publicado: (2016) -
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2021) -
Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020)